Pathophysiology of Heart Failure in Regurgitant Valvular Diseases: Relation to Ventricular Dysfunction and Clinical Debility

  • Jeffrey S. Borer
  • Edmund M. Herrold
  • Clare A. Hochreiter
  • Sharada L. Truter
  • John N. Carter
  • Steven M. Goldfine
Part of the Basic Science for the Cardiologist book series (BASC, volume 2)


Regurgitant valvular heart diseases and, most particularly, insufficiency of the aortic and/or mitral valves (AR, MR), are among the more common, and most predictable, causes of congestive heart failure. Current data suggest that these conditions also confer a proclivity for sudden death, even among asymptomatic or minimally symptomatic patients (1,2,3).


Left Ventricle Mitral Regurgitation Right Ventricle Aortic Valve Replacement Aortic Regurgitation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Borer JS, Hochreiter C, Herrold EM, Supino P, Aschermann M, Wencker D, Devereux RB, Roman MJ, Szulc M, Kligfield P, Isom OW. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance. Circulation 1998; 97:525–534.PubMedGoogle Scholar
  2. 2.
    Hochreiter C, Niles N, Devereux RB, Kligfield P, Borer JS. Mitral regurgitation: relationship of non-invasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 1986;73:900–912.PubMedGoogle Scholar
  3. 3.
    Kligfield P, Hochreiter C, Niles N, Devereux RB, Borer JS. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. American Journal of Cardiology 1987;60:397–399.PubMedCrossRefGoogle Scholar
  4. 4.
    Magid NM, Young MS, Wallerson DC, Goldweit RS, Carter JN, Devereux RB, Borer JS. Hypertrophic and functional response to experimental chronic aortic regurgitation. Journal of Molecular and Cellular Cardiology 1988;20:239–246.PubMedCrossRefGoogle Scholar
  5. 5.
    Yamazaki T, Uematsu T, Mizuno A, Takiguchi Y, Nakashima M. Alterations of cardiac adrenoceptors and calcium channels subsequent to production of aortic insufficiency in rats. Arch Int Pharmacodyn Ther 1989;299:155–168.PubMedGoogle Scholar
  6. 6.
    Weber KT, Brilla CG. Pathological hypertrophy and the cardiac interstitium. Fibrosis and the renin-angiotensin-aldosterone system. Circulation 1991; 83:1849–1865.PubMedGoogle Scholar
  7. 7.
    Liu S-K, Magid NM, Fox PR, Goldfine SM, Borer JS. Fibrosis, myocyte degeneration and heart failure in chronic experimental aortic regurgitation. Cardiology, 1998, in press.Google Scholar
  8. 8.
    Reid CL, Gardin JM, Yunis C, Kurosaki T, Flack JM, for the Coronary Artery Risk Development inYoung Adults Research Group. Prevalence and clinical correlates of aortic and mitral regurgitation in young adult population: The Cardia Study. Circulation 1994;90(Suppl I):I–282(Abs).Google Scholar
  9. 9.
    Siemienczuk D, Greenberg B, Morris C, Massie B, Wilson RA, Topic N, Bristow JD, Cheitlin M. Chronic aortic insuffiency: factors associated with progression to aortic valve replacement. Ann Intern Med. 1989;110–587–592.Google Scholar
  10. 10.
    Bonow RO, Rosing DR, Mclntosh CL, Jones M, Maron BJ, Lan KKG, Lakatos E, Bacharach SL, Green MV, Epstein SE. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation. 1983;68:509–517.PubMedGoogle Scholar
  11. 11.
    Linsay J, Silverman A, Van Voorhees LB, Nolan NG. Prognostic implications of left ventricular function during exercise in asymptomatic patients with aortic regurgitation. Angiology 1987;38:386–392.Google Scholar
  12. 12.
    Henry WL, Bonow RO, Borer JS, Ware JH, Kent KM, Redwood DR, Mclntosh CL, Morrow AG, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation, I: evaluation of the results of aortic valve replacement in symptomatic patients. Circulation 1980;61:471–483.PubMedGoogle Scholar
  13. 13.
    Borer JS, Hochreiter C, Herrold EM, Roman MJ, Kligfield P, Szulc M, Supino P, Isom OW, Krieger K, Kaufman JD. Prediction of outcome late after aortic valve replacement for aortic regurgitation utilizing pre-operative wall-stress-sdjusted change in ejection fraction from rest to exercise. Circulation 1998; in press (Abs).Google Scholar
  14. 14.
    Borer JS, Herrold EM, Hochreiter C, Roman M, Supino P, Devereux RB, Kligfield P, Nawaz H. Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. Circulation 1991;84(Suppl IH):III-133–III-139.Google Scholar
  15. 15.
    Enrique-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 1994;90:830–837.Google Scholar
  16. 16.
    Philips HR, Levine FH, Carter JE, Boucher C, Osbakken MD, Okada RD, Akins CW, Daggett WM, Buckley MJ, Pohost GM. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. American Journal of Cardiology 1981;48: 647–654.CrossRefGoogle Scholar
  17. 17.
    Rosen S, Borer JS, Hochreiter C, Supino P, Roman M, Devereux RB, Kligfield P. Natural history of the asymptomatic/minimally symptomatic patient with normal right and left ventricular performance and severe mitral regurgitation due to mitral valve prolapse. American Journal of Cardiology 1994;74:374–380.PubMedCrossRefGoogle Scholar
  18. 18.
    Borer JS, Wencker D, Hochreiter C. Management decisions in valvular heart disease: the role of radionuclide-based assessment of ventricular function and performance. Journal of Nuclear Cardiology 1996:3:72–81.PubMedCrossRefGoogle Scholar
  19. 19.
    Magid NM, Borer JS, Young MS, Wallerson DC, De Monteiro C. Suppression of protein degradation in progessive cardiac hypertrophy of chronic aortic regurgitation. Circulation 1993;871249–1257.Google Scholar
  20. 20.
    Leiden JM. The genetics of dilated cardiomyopathy-emerging clues to the puzzle. New England J Med 1997;337:1080–1081.CrossRefGoogle Scholar
  21. 21.
    Magid NM, Opio G, Wallerson DC, Young MS, Borer JS. Heart failure due to chronic experimental aortic regurgitation. American J Physiology 1994;267:H556–562.Google Scholar
  22. 22.
    Magid NM, Wallerson DC, Bent SJ, Borer JS. Hypertrophy and heart failure in chronic experimental mitral regurgitation. J American College Cardiology 1994;23(Special Issue): 248A (Abs.).Google Scholar
  23. 23.
    Young MS, Magid NM, Wallerson DC, Goldweit RS, Devereux RB, Carter JN, Im J, Hall MA, Borer JS. Echocardiographic left ventricular mass measurement in small animals: anotomic validation in normal and aortic regurgitant rabbits. American Journal of Noninvasive Cardiology 1990;4:145–153.Google Scholar
  24. 24.
    King RK, Magid NM, Opio G, Borer JS. Protein turnover in compensated chronic aortic regurgitation. Cardiology 1997;88:518–525.PubMedGoogle Scholar
  25. 25.
    Magid NM, Opio G, Wallerson DC, Borer JS. Suppressed protein turnover in congestive heart failure due to severe chronic aortic regurgitation. Circulation 1992;86:I–540.Google Scholar
  26. 26.
    Carter JN, Borer JS, Jacobson MN, Herrold EM, Magid NM. Myofibrillar protein synthesis rates in mitral regurgitation. Circulation 1997;96(Suppl I): 1–469 (Abs).Google Scholar
  27. 27.
    Herrold EM, Lu P, Zanzonic P, Goldfine SM, Szulc M, Magid NM, Borer JS. Antimyosin antibody-mediated detection of myocardial injury: relation to wall stress in chronic aortic regurgitation. Computers in Cardiology 1995; IEEE Publication #0276-6547/95: 59–62.Google Scholar
  28. 28.
    Oldershaw PJ, Brooksby IAB, Davies MJ, Coltart DJ, Jenkins BS, Webb-Peploe MM: Correlations of fibrosis in endomyocardial biopsies from patients with aortic valve disease. B Heart J 1980; 44:609–611.CrossRefGoogle Scholar
  29. 29.
    Donaldson RM, Florio R, Rickards AF, et al: Irreversible morphological changes contributing to depressed cardiac function after surgery for chronic aortic regurgitation. B Heart J 1982;48:589–597.CrossRefGoogle Scholar
  30. 30.
    Hannafin JA, personal communication.Google Scholar
  31. 31.
    Lu P, Zanzonico P, Goldfine SM, Hardoff R, Gentile R, Magid N, Herrold EM, Borer JS. Antimyosin antibody imaging in experimental aortic regurgitation. Journal of Nuclear Cardiology 1997;4:25–32.PubMedCrossRefGoogle Scholar
  32. 32.
    Herrold EM, Carter JN, Borer JS. Volume-overload-related shape change limits mass increase with wall thickening but only minimally reduces wall stress. Computers in Cardiology, 1992; IEEE publication #0276-6547/92:287–290.Google Scholar
  33. 33.
    Herrold EM, Goldfine SM, Magid NM, Borer JS. Myocardial blood flow in aortic regurgitation: computer-based predictions from wall stress compared with fluorescent microsphere measurements. Computers in Cardiology 1994; IEEE Publications #0276-6547/94:729–732.Google Scholar
  34. 34.
    Goldfine SM, Pena M, Magid NM, Liu S-K, Borer JS. Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation. American Journal of Therapeutics, in press, 1998.Google Scholar
  35. 35.
    Borer JS, Pena M, Falcone D, Truter S, Goldfine S. Chronic aortic regurgitation causes fibrosis featuring hyper-production of non-collogen, glucosamine-containing matrix elements. J American College of Cardiology (Abstract), submitted, action pending 1999.Google Scholar
  36. 36.
    Goldin D, Borer JS, Goldfine SM. Abnormal gene expression of cardiac fibroblasts in experimental aortic regurgitation. Circulation 1997; 96(Suppl I): I–205(Abs).Google Scholar
  37. 37.
    Gimbrone MA, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 1997;99:1809–1813.PubMedCrossRefGoogle Scholar
  38. 38.
    Truter S, Kolesar J, Dumlao T, Borer JS. Chronic aortic regurgitation causes abnormal cardiac fibroblast gene expression leading to myocardial fibrosis. J American College Cardiology (Abs.), submitted, action pending 1999.Google Scholar
  39. 39.
    Liu F, Truter SL, Magda P, Borer JS. Aortic regurgitation alters the expression of dihydropyridine-sensitive L-type calcium channels in cardiac fibroblasts. J American College of Cardiology 1998; 31(Suppl A):424A(Abs.).CrossRefGoogle Scholar
  40. 40.
    Ross JS, Goldfine SM, Herrold EM, Borer JS. Differential response to vesnarinone by cardiac fibroblasts isolated from normal and aortic regurgitation hearts. American Journal of Therapeutics 1998, in press.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Jeffrey S. Borer
    • 1
  • Edmund M. Herrold
    • 1
  • Clare A. Hochreiter
    • 1
  • Sharada L. Truter
    • 1
  • John N. Carter
    • 1
  • Steven M. Goldfine
    • 1
  1. 1.Cornell Univeristy Medical CollegeUSA

Personalised recommendations